Otonomy Inc. | Mutual Funds
Mutual Funds that own Otonomy Inc.
Vanguard Total Stock Market Index Fund
499,546
1.63%
0
0%
07/31/2018
Wellington Mgmt. Port (Dublin) Plc - Global Health Care Eq.
437,909
1.43%
229,909
0.06%
12/31/2017
Vanguard Extended Market Index Fund
376,517
1.23%
0
0%
07/31/2018
DFA US Targeted Value Portfolio
260,454
0.85%
31,251
0.01%
04/30/2018
DFA US Small Cap Portfolio
247,002
0.81%
54,834
0%
04/30/2018
CREF Stock Account
229,413
0.75%
-2,920
0%
03/31/2018
BNY Mellon Small Cap Multi Strategy Fund
159,425
0.52%
0
0.07%
05/31/2018
DFA US Micro Cap Portfolio
154,270
0.51%
40,174
0.01%
04/30/2018
Northwestern Mutual-Small Cap Growth Stock Portfolio
138,409
0.45%
0
0.06%
12/31/2017
Fidelity Spartan Extended Market Index Fund
111,539
0.37%
0
0%
07/31/2018
| Address |
4796 Executive Drive
San Diego California 92121
United States
|
|
Employees
|
- |
| Website |
http://www.otonomy.com |
| Updated |
07/08/2019 |
| Otonomy, Inc. is a biopharmaceutical company, which engages in the research, development, and manufacture of therapeutics for otology. The firm's portfolio includes therapeutics for diseases and disorders of the ear such as Ménière's disease, tinnitus, synaptopathy hearing loss, cisplatin-induced loss, severe hearing loss, TTP surgery, and acute otitis externa. It operates under the Otiprio brand. |
